CM
ORGO icon

Castleark Management’s Organogenesis Holdings ORGO Stock Holding History

Castleark Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-332,297
Closed -$4.73M – 354
2021
Q3 		$4.73M Buy
332,297
+12,700
+4% +$197K 0.18% 129
2021
Q2 		$5.31M Buy
+319,597
New +$5.96M 0.18% 136

Other funds holding ORGO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Castleark Management's ORGO Position: Q4 2021 in Review

Castleark Management sold out of Organogenesis Holdings (ORGO) in Q4 2021, closing a stake of 332,297 shares — an estimated $4.73M sold.

Castleark Management first reported a position in ORGO in Q2 2021 and held it in 2 quarters. The position peaked at $5.31M in Q2 2021. 157 funds tracked by Wall St. Rank hold ORGO as of Q4 2021.

  • Castleark Management reported no remaining Organogenesis Holdings position as of Q4 2021 after selling out during the quarter.
  • Castleark Management sold 332,297 Organogenesis Holdings shares in Q4 2021, an estimated $4.73M.
  • Castleark Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 2 quarters.
  • Castleark Management's Organogenesis Holdings position peaked at $5.31M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2021.

Based on Castleark Management's 13F filing for Q4 2021, filed 16 Feb 2022.